Prolific Machines

Understand our Platform’s innovative capabilties

At this stage, we’re focused on co-development partnerships, providing select partners with limited early access to our groundbreaking technology.

For proof-of-concept studies, we generally follow an R&D fee-for-service model, with clearly defined project milestones and associated costs.

For projects closer to commercialization, we offer a more flexible approach, which can include technical milestones, phased payments, and discussions around royalty payments for products produced with our photomolecular platform. Additionally, we can negotiate exclusive licenses for specific product categories, ensuring that your investment is fully protected and aligned with your long-term strategic goals.

Our business model varies from licensing the technology to joint ventures and offering customized optogenetics solutions or services to partners in the biotech and pharma industries. This flexibility allows us to adapt our approach to meet the specific requirements and strategic objectives of each partner.